OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives
Janet Sultana, Ugo Moretti, Antonio Addis, et al.
Drug Safety (2018) Vol. 42, Iss. 5, pp. 683-687
Closed Access | Times Cited: 7
Janet Sultana, Ugo Moretti, Antonio Addis, et al.
Drug Safety (2018) Vol. 42, Iss. 5, pp. 683-687
Closed Access | Times Cited: 7
Showing 7 citing articles:
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation (2024) Vol. 3
Open Access | Times Cited: 32
Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation (2024) Vol. 3
Open Access | Times Cited: 32
Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
Sieta T. de Vries, Petra Denig, Carmen Lasheras Ruiz, et al.
Drug Safety (2018) Vol. 41, Iss. 7, pp. 697-712
Open Access | Times Cited: 32
Sieta T. de Vries, Petra Denig, Carmen Lasheras Ruiz, et al.
Drug Safety (2018) Vol. 41, Iss. 7, pp. 697-712
Open Access | Times Cited: 32
Expert opinion on Real World Evidence RWE in drug development and usage
N. Martini, G. Trifirò, A. Capuano, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 13
N. Martini, G. Trifirò, A. Capuano, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 13
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy
Cláudia Rossi, Rosanna Ruggiero, Liberata Sportiello, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5104-5104
Open Access | Times Cited: 7
Cláudia Rossi, Rosanna Ruggiero, Liberata Sportiello, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5104-5104
Open Access | Times Cited: 7
What can real world evidence contribute to regulatory science in pre and post marketing setting?
N. Martini, J. Sultana, Addis, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 5
N. Martini, J. Sultana, Addis, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 5
Expert opinion on Real World Evidence RWE in drug development and usage
N. Martini, Giuliana Trifirò, Annalisa Capuano, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 2
N. Martini, Giuliana Trifirò, Annalisa Capuano, et al.
(2020) Vol. 02, Iss. 02
Open Access | Times Cited: 2
What can real world evidence contribute to regulatory science in pre and post marketing setting?
Ni Putu Surya Martini, Jamie Sultana, Addis, et al.
(2020) Vol. 02, Iss. 02
Open Access
Ni Putu Surya Martini, Jamie Sultana, Addis, et al.
(2020) Vol. 02, Iss. 02
Open Access
